BREYANZI is a prescription medicine used to treat large B cell lymphoma, a type of non-Hodgkin lymphoma, when:
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
The phrase “line of therapy” describes the order in which different cancer treatments are given.
First line therapy
The first treatment after diagnosis
later lines of therapy
Treatment given if the cancer returns or doesn’t respond to previous treatment
Breyanzi CAR T cell therapy may be an option.
Your diagnosis and treatment history:
Are you an adult with large B-cell lymphoma?
Do you have large B-cell lymphoma that
started in your brain and/or spinal cord?
Have you had at least 1 previous treatment
for large B-cell lymphoma treatment?
Your healthcare team will consider your clinical fitness by assessing how the cancer is affecting your daily life.
A partner throughout the treatment process
You must have a care partner to receive Breyanzi. Your care partner can be a family member or friend who is able to be with you for about 2 to 3 months.
There are other treatment and clinical factors your healthcare team will consider.
Always talk with your healthcare team about treatment options that may be right for you.